These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26993605)

  • 1. Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOFMS assay.
    Jia K; Li W; Wang F; Qu H; Qiao Y; Zhou L; Sun Y; Ma Q; Zhao X
    Oncotarget; 2016 Apr; 7(17):23569-80. PubMed ID: 26993605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Liu LH; Shan BE; Tian ZQ; Sang MX; Ai J; Zhang ZF; Meng J; Zhu H; Wang SJ
    Clin Chem Lab Med; 2010 Jun; 48(6):855-61. PubMed ID: 20345231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.
    Zhao J; Fan YX; Yang Y; Liu DL; Wu K; Wen FB; Zhang CY; Zhu DY; Zhao S
    Int J Clin Exp Pathol; 2015; 8(2):1535-44. PubMed ID: 25973038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma.
    Xu YW; Peng YH; Ran LQ; Zhai TT; Guo HP; Qiu SQ; Chen HL; Wu ZY; Li EM; Xie JJ
    Clin Transl Oncol; 2017 Jul; 19(7):898-906. PubMed ID: 28181176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
    Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G
    Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubulin beta chain, filamin A alpha isoform 1, and cytochrome b-c1 complex subunit 1 as serological diagnostic biomarkers of esophageal squamous cell carcinoma: a proteomics study.
    Fan NJ; Gao CF; Wang XL
    OMICS; 2013 Apr; 17(4):215-23. PubMed ID: 23496306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma.
    Gao SG; Yang JQ; Ma ZK; Yuan X; Zhao C; Wang GC; Wei H; Feng XS; Qi YJ
    BMC Cancer; 2018 Jan; 18(1):17. PubMed ID: 29298684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between serum Dickkopf-1 levels and esophageal squamous cell carcinoma.
    Begenik H; Kemik AS; Emre H; Dulger AC; Demirkiran D; Ebinc S; Kemik O
    Hum Exp Toxicol; 2014 Aug; 33(8):785-8. PubMed ID: 24220876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.
    Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
    Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of haptoglobin peptide as a novel serum biomarker for lung squamous cell carcinoma by serum proteome and peptidome profiling.
    Okano T; Seike M; Kuribayashi H; Soeno C; Ishii T; Kida K; Gemma A
    Int J Oncol; 2016 Mar; 48(3):945-52. PubMed ID: 26783151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum proteomic spectra of esophageal squamous cell carcinoma patients analyzed with IMAC3 protein chip].
    Liu CZ; Zhu PY; Shi MX; Liu JB; Liao P; Xiang CQ; Zhang YX; Wang WJ
    Ai Zheng; 2008 Mar; 27(3):272-8. PubMed ID: 18334116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma.
    Xu YW; Liu CT; Huang XY; Huang LS; Luo YH; Hong CQ; Guo HP; Xu LY; Peng YH; Li EM
    Dis Markers; 2017; 2017():5384091. PubMed ID: 28852266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of clusterin both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches.
    Zhang LY; Ying WT; Mao YS; He HZ; Liu Y; Wang HX; Liu F; Wang K; Zhang DC; Wang Y; Wu M; Qian XH; Zhao XH
    World J Gastroenterol; 2003 Apr; 9(4):650-4. PubMed ID: 12679903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of serum peptidome patterns of esophageal squamous cell carcinoma patients for comprehensive treatment.
    Wan QL; Hou XS; Zhao G
    Asian Pac J Cancer Prev; 2013; 14(5):2919-23. PubMed ID: 23803054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative serum proteomic analysis of serum diagnosis proteins of colorectal cancer based on magnetic bead separation and maldi-tof mass spectrometry.
    Deng BG; Yao JH; Liu QY; Feng XJ; Liu D; Zhao L; Tu B; Yang F
    Asian Pac J Cancer Prev; 2013; 14(10):6069-75. PubMed ID: 24289627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of extracellular matrix protein 1 as a potential plasma biomarker of ESCC by proteomic analysis using iTRAQ and 2D-LC-MS/MS.
    Wang X; Peng Y; Xie M; Gao Z; Yin L; Pu Y; Liu R
    Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28493612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining proteomics, serum biomarkers and bioinformatics to discriminate between esophageal squamous cell carcinoma and pre-cancerous lesion.
    Zhai XH; Yu JK; Lin C; Wang LD; Zheng S
    J Zhejiang Univ Sci B; 2012 Dec; 13(12):964-71. PubMed ID: 23225851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum peptidome patterns for early screening of esophageal squamous cell carcinoma.
    Fan NJ; Gao CF; Zhao G; Wang XL; Qiao L
    Biotechnol Appl Biochem; 2012; 59(4):276-82. PubMed ID: 23586861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
    Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
    Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis.
    Yang YF; Li H; Xu XQ; Diao YT; Fang XQ; Wang Y; Zhao DL; Wu K; Li HQ
    Dis Esophagus; 2008; 21(5):395-401. PubMed ID: 19125792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.